RemOmics is a company that presents cutting-edge bioinformatics, computational systems biology, and cheminformatics analytical services through a user-friendly and streamlined platform.
Also, RemOmics produces computational systems omics-powered remedies. We develop novel data- and AI-based medicines for the treatment of a variety of different diseases and health problems.
Company Details
- Founded
- 2023
- Address
- Melbourne, Vic, Au
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://RemOmics.com
- Keywords
- Bioinformatics, Computational Systems Biology, Computational Systems Omics, Machine Learning, ML, AI, Artificial Intelligence, AI-based medicines, Cheminformatics, Computer-aided Drug Design, Drug development, Drug Repurposing.
- HQ
- Melbourne, VIC
- Competitors
- BioCommunicator, Radiology AI, MACSYS - ARC Centre of Excellence for the Mathematical Analysis of Cellular Systems, Moyi Health Tech, National Centre for Spatial Tissue and AI Research (NCSTAR), Sanux, MOL Diagnostics, Synapse, Duke-NUS AI + Medical Sciences Initiative (DAISI), Promethean Systems.
Remomics Questions
Remomics's website is http://RemOmics.com
Remomics's LinkedIn profile is https://au.linkedin.com/company/remomics
Remomics's industry is
Biotechnology Research
Remomics's top competitors are
Biocommunicator,
Radiology Ai,
Macsys - Arc Centre Of Excellence For The Mathematical Analysis Of Cellular Systems,
Moyi Health Tech,
National Centre For Spatial Tissue And Ai Research (Ncstar),
Sanux,
Mol Diagnostics,
Synapse,
Duke-Nus Ai + Medical Sciences Initiative (Daisi),
Promethean Systems.
Remomics's categories are Biotechnology Research
Remomics's founding year is 2023
